We joined Europe’s Premier Innovation Conference at the 2022 ISPIM Innovation Conference, a hybrid event that took place in Copenhagen from 5-8 June. A great opportunity to connect with innovation professionals from academia, industry, public service and consulting in a multidisciplinary act with worldwide attendees. The experts could take part in workshops, hot-topic discussions and discussion panels as well as sessions on the latest academic research results and industry cases. Four days of thought-provoking innovation discussions, with 450 innovation professionals from 40 countries, more than 270 presentations with innovation management insights from industry and research and more than 70 workshops and panel discussions to engage with.
Under the title “An Innovation Network-based Incubation Strategy to Accelerate Digital Health Spin-Offs”, Cristina Páez, Business Development at Xartec Salut, introduced the network’s main activity to all the attendees. “So far, the network has been boosting digital transformation, technology transfer and valorization strategies through several calls, supporting the creation of 10 spin-offs and accelerating more than 20 projects. These results demonstrate that Xartec Salut’s strategies are required to make research profitable, foster collaboration and the inclusion of patients in the early stages of the R&D process”, explained.
Xartec Salut team also joined the ecosystem in the 10th edition of #SouthSummit held in Madrid, a great opportunity to keep building bridges for HealthTech innovation. Innovation, entrepreneurship and trends accompanied by music and party. What more could you need?
An event that served to create opportunities and give visibility to innovation with 40% of startups, 30% Corporates and 12% of investors. Moren than 650 speakers, 220 media and 220 funds 220 funds with $250B funds under management.
By attending this major events, Xartec Salut keeps its focus on reducing the gap between research and impact on the market, generating tools that facilitate the arrival of technologies that address the needs of the health world. All these ambitious goals described above are carried out by a great team formed by Sergio San Agustín, Alexandre Perera, Berta Borràs, Manel González-Piñero, Cristina Páez, Antonio Galicia, Álvaro Martínez and Anna Turón.
This project is co-financed by the European Union through the European Regional Development Fund (ERDF).